Targeting FAK in human cancer: from finding to first clinical trialsVita Golubovskaya(Promega (United States))Frontiers in bioscienceJanuary 1, 201410.2741/4236Cited by 201SaveCiteExport RISWatch citationsRelated PapersmRNA-Lipid Nanoparticle (LNP) Delivery of Humanized EpCAM-CD3 Bispecific Antibody Significantly Blocks Colorectal Cancer Tumor Growth|Cancers|2023|28CAR-T Cells Based on Novel BCMA Monoclonal Antibody Block Multiple Myeloma Cell Growth|Cancers|2018|24Dual Inhibition of Focal Adhesion Kinase and Epidermal Growth Factor Receptor Pathways Cooperatively Induces Death Receptor-mediated Apoptosis in Human Breast Cancer Cells|UNC Libraries|2021|0